Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PSA-negative/low prostate cancer cells: the true villains of CRPC?

Literature DB >> 22820854

PSA-negative/low prostate cancer cells: the true villains of CRPC?

David J Mulholland¹.

Abstract

Entities: Disease

Year: 2012 PMID： 22820854 PMCID： PMC3734974 DOI： 10.1038/aja.2012.69

Source DB: PubMed Journal: Asian J Androl ISSN： 1008-682X Impact factor: 3.285

× No keyword cloud information.

17 in total

Review 1. Castration-resistant prostate cancer: from new pathophysiology to new treatment targets.

Authors: Kim N Chi; Anders Bjartell; David Dearnaley; Fred Saad; Fritz H Schröder; Cora Sternberg; Bertrand Tombal; Tapio Visakorpi
Journal: Eur Urol Date: 2009-06-24 Impact factor: 20.096

2. Stem-like cells with luminal progenitor phenotype survive castration in human prostate cancer.

Authors: Markus Germann; Antoinette Wetterwald; Natalia Guzmán-Ramirez; Gabri van der Pluijm; Zoran Culig; Marco G Cecchini; Elizabeth D Williams; George N Thalmann
Journal: Stem Cells Date: 2012-06 Impact factor: 6.277

3. Cancer statistics, 2010.

Authors: Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal: CA Cancer J Clin Date: 2010-07-07 Impact factor: 508.702

4. Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth.

Authors: David J Mulholland; Linh M Tran; Yunfeng Li; Houjian Cai; Ashkan Morim; Shunyou Wang; Seema Plaisier; Isla P Garraway; Jiaoti Huang; Thomas G Graeber; Hong Wu
Journal: Cancer Cell Date: 2011-05-27 Impact factor: 31.743

5. Distant metastases from prostatic carcinoma express androgen receptor protein.

Authors: A Hobisch; Z Culig; C Radmayr; G Bartsch; H Klocker; A Hittmair
Journal: Cancer Res Date: 1995-07-15 Impact factor: 12.701

Review 6. Targeting the androgen receptor pathway in prostate cancer.

Authors: Yu Chen; Charles L Sawyers; Howard I Scher
Journal: Curr Opin Pharmacol Date: 2008-08-12 Impact factor: 5.547

7. Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.

Authors: Elahe A Mostaghel; Stephanie T Page; Daniel W Lin; Ladan Fazli; Ilsa M Coleman; Lawrence D True; Beatrice Knudsen; David L Hess; Colleen C Nelson; Alvin M Matsumoto; William J Bremner; Martin E Gleave; Peter S Nelson
Journal: Cancer Res Date: 2007-05-15 Impact factor: 12.701

8. Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer.

Authors: J A Ruizeveld de Winter; P J Janssen; H M Sleddens; M C Verleun-Mooijman; J Trapman; A O Brinkmann; A B Santerse; F H Schröder; T H van der Kwast
Journal: Am J Pathol Date: 1994-04 Impact factor: 4.307

9. The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.

Authors: Jichao Qin; Xin Liu; Brian Laffin; Xin Chen; Grace Choy; Collene R Jeter; Tammy Calhoun-Davis; Hangwen Li; Ganesh S Palapattu; Shen Pang; Kevin Lin; Jiaoti Huang; Ivan Ivanov; Wei Li; Mahipal V Suraneni; Dean G Tang
Journal: Cell Stem Cell Date: 2012-05-04 Impact factor: 24.633

10. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors: Can Liu; Kevin Kelnar; Bigang Liu; Xin Chen; Tammy Calhoun-Davis; Hangwen Li; Lubna Patrawala; Hong Yan; Collene Jeter; Sofia Honorio; Jason F Wiggins; Andreas G Bader; Randy Fagin; David Brown; Dean G Tang
Journal: Nat Med Date: 2011-01-16 Impact factor: 53.440

3 in total

PSA-negative/low prostate cancer cells: the true villains of CRPC?

Review 1. Castration-resistant prostate cancer: from new pathophysiology to new treatment targets.

2. Stem-like cells with luminal progenitor phenotype survive castration in human prostate cancer.

3. Cancer statistics, 2010.

4. Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth.

5. Distant metastases from prostatic carcinoma express androgen receptor protein.

Review 6. Targeting the androgen receptor pathway in prostate cancer.

7. Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.

8. Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer.

9. The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.

10. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Review 1. Ca²⁺ as a therapeutic target in cancer.

Review 2. New insights into prostate cancer stem cells.

3. AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression.

Review 1. Castration-resistant prostate cancer: from new pathophysiology to new treatment targets.

Review 6. Targeting the androgen receptor pathway in prostate cancer.

Review 1. Ca2+ as a therapeutic target in cancer.

Review 2. New insights into prostate cancer stem cells.

Review 1. Ca²⁺ as a therapeutic target in cancer.